Longitudinal Digital Mood Charting in Bipolar Disorder: Experiences with ChronoRecord Over 20 Years
Pharmacopsychiatry · 01.09.2023 · 56 (05) · 182-187
DOI: 10.1055/a-2156-5667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacopsychiatry, erschienen am 01.09.2023. Verfasst von Michael Bauer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: Bipolar Disorder, Depressive Disorder. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Longitudinal study is an essential methodology for understanding disease trajectories, treatment effects, symptom changes, and long-term outcomes of affective disorders. Daily self-charting of mood and other illness-related variables is a commonly recommended intervention. With the widespread acceptance of home computers in the early 2000s, automated tools were developed for patient mood charting, such as ChronoRecord, a software validated by patients with bipolar disorder. The purpose of this study was to summarize the daily mood, sleep, and medication data collected with ChronoRecord, and highlight some of the key research findings. Lessons learned from implementing a computerized tool for patient self-reporting are also discussed.
Methods
After a brief training session, ChronoRecord software for daily mood charting was installed on a home computer and used by 609 patients with affective disorders.
Results
The mean age of the patients was 40.3±11.8 years, a mean age of onset was 22±11.2 years, and 71.4% were female. Patients were euthymic for 70.8% of days, 15.1% had mild depression, 6.6% had severe depression, 6.6% had hypomania, and 0.8% had mania. Among all mood groups, 22.4% took 1–2 medications, 37.2% took 3–4 medications, 25.7 took 5–6 medications, 11.6% took 7–8 medications, and 3.1% took >8 medications.
Conclusion
The daily mood charting tool is a useful tool for increasing patient involvement in their care, providing detailed patient data to the physician, and increasing understanding of the course of illness. Longitudinal data from patient mood charting was helpful in both clinical and research settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Psychiatry and Psychotherapy, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
- ChronoRecord Association Inc., Fullerton, CA, USA, www.chronorecord.org.
- Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
- Department of Psychiatry, University of Toronto, ON, Canada (retired) and Mood Disorders Center of Ottawa, Ottawa, Canada.
- Karlsruhe Institute of Technology, Institute of Sports and Sports Science, Karlsruhe, Germany.
- Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Germany.
Zitieren
APA
Bauer, M., Glenn, T., Alda, M., Grof, P., Bauer, R., Ebner-Priemer, U. W., Ehrlich, S., Pfennig, A., Pilhatsch, M., Rasgon, N., & Whybrow, P. C. (2023). Longitudinal Digital Mood Charting in Bipolar Disorder: Experiences with ChronoRecord Over 20 Years. Pharmacopsychiatry, 56(05), 182-187. https://doi.org/10.1055/a-2156-5667
Vancouver
Bauer M, Glenn T, Alda M, Grof P, Bauer R, Ebner-Priemer UW, et al. Longitudinal Digital Mood Charting in Bipolar Disorder: Experiences with ChronoRecord Over 20 Years. Pharmacopsychiatry. 2023;56(05):182-187. doi:10.1055/a-2156-5667
BibTeX
@article{Bauer2023,
author = {Bauer, Michael and Glenn, Tasha and Alda, Martin and Grof, Paul and Bauer, Rita and Ebner-Priemer, Ulrich W and Ehrlich, Stefan and Pfennig, Andrea and Pilhatsch, Maximilian and Rasgon, Natalie and Whybrow, Peter C},
title = {Longitudinal Digital Mood Charting in Bipolar Disorder: Experiences with ChronoRecord Over 20 Years},
journal = {Pharmacopsychiatry},
year = {2023},
volume = {56},
number = {05},
pages = {182--187},
doi = {10.1055/a-2156-5667}
}
EUVIMED